420 with CNW – Opioid Alternative Launched in California by Cannabis Company

October 11, 2018 15:20:42

C3 International recently launched a ground-breaking painkiller derived from cannabis as an alternative to the conventional prescription opioids that have been linked to so many issues, such as the possibility of addiction, constipation, incoherence, loss of appetite and other side effects.

The pill made by C3 International is unique because it is a standardized product that can be trusted to deliver the same results at a given dosage for those who use it.

The company says that its product doesn’t have any psychoactive ingredients since only CBD was extracted and added to a formulation of other ingredients calculated to provide different doses of cannabis based on the needs of a patient.

The tablet provides an easy way for doctors to prescribe and ensure that a patient is consuming the required quantity of the therapeutic product within the stipulated intervals.

This is different from what has been happening with the existing edible or smoking marijuana products whose medicinal content often varied from one batch purchased to the next. It is also common for the ingredients to vary from one plant to another. This makes it hard to be certain that the patient is receiving the exact quantity of curative ingredients to produce the desired results without triggering any unwanted effects.

The ingredients used to make the new pill are extracted from cloned plants which yield a uniform amount and quality of the desired ingredients. One can therefore be sure that each pill will contain exactly the same amount of ingredients as any other pill made by the same manufacturer.

Unfortunately, this product is only available within the state of California, so patients elsewhere may have to wait. Federal laws prohibit marijuana or any products derived from it to cross state lines, so the new pill cannot be provided outside California.

Those who are within California may also be pleased to learn that several insurance providers will cover the cost of getting these novel pills. One simply has to contact their insurer and confirm that the company can be billed for the cannabis pills.

The pill launched by C3 International is likely to be one of many new products which will hit the market in the states where marijuana has been decriminalized in some form. If one could only take a sneak peek into Sugarmade, Inc. (OTCQB: SGMD) and Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) to learn what they intend to introduce on the rapidly evolving marijuana market!

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
303.498.7722 Office